Heval Atas

发表

How to Best Represent Proteins in Machine Learning-based Prediction of Drug/Compound-Target Interactions

Tunca Doğan, Heval Atas, Tunca Dogan, 2022, bioRxiv.

How to Approach Machine Learning-based Prediction of Drug/Compound-Target Interactions

Tunca Doğan, Heval Atas, 2022, bioRxiv.

Anti-cancer effect of clofazimine as a single agent and in combination with cisplatin on U266 multiple myeloma cell line.

Heval Atas, Ayşenur Biber, Selin Gerekçi, 2017, Leukemia research.

Data Centric Molecular Analysis and Evaluation of Hepatocellular Carcinoma Therapeutics Using Machine Intelligence-Based Tools

R. Cetin-Atalay, D. Kahraman, A. Rifaioglu, 2021, Journal of Gastrointestinal Cancer.

Recent applications of deep learning and machine intelligence on in silico drug discovery: methods, tools and databases

Volkan Atalay, Heval Atas, Rengul Cetin-Atalay, 2018, Briefings Bioinform..

CROssBAR: comprehensive resource of biomedical relations with knowledge graph representations

R. Cetin-Atalay, V. Atalay, M. Martin, 2021, Nucleic acids research.

Learning functional properties of proteins with language models

K. Turhan, Muammer Albayrak, Heval Atas, 2022, Nature Machine Intelligence.

Phylogenetic and Other Conservation-Based Approaches to Predict Protein Functional Sites.

Nurcan Tuncbag, Heval Atas, Tunca Doğan, 2018, Methods in molecular biology.

Protein Domain-Based Prediction of Compound–Target Interactions and Experimental Validation on LIM Kinases

R. Cetin-Atalay, M. Martin, M. Baumann, 2021, bioRxiv.

Evaluation of Methods for Protein Representation Learning: A Quantitative Analysis

Muammer Albayrak, Aybar C. Acar, Tunca Doğan, 2020, bioRxiv.

CROssBAR: Comprehensive Resource of Biomedical Relations with Deep Learning Applications and Knowledge Graph Representations

Volkan Atalay, Rabie Saidi, Heval Atas, 2020, bioRxiv.

Recent applications of deep learning and machine intelligence on in silico drug discovery: methods, tools and databases

R. Cetin-Atalay, V. Atalay, M. Martin, 2018, Briefings Bioinform..

Protein domain-based prediction of drug/compound–target interactions and experimental validation on LIM kinases

Ece Akhan Güzelcan, R. Cetin-Atalay, I. Baxendale, 2021, PLoS Comput. Biol..